Save your seat for this upcoming customer webinar! Learn about TFS International and their reasons for adopting custom built study startup technology.
Title: TFS & Technology – Our Approach to Study Start-Up
Study startup, encompassing activities associated with site identification, feasibility assessment, selection and activation, is a notorious bottleneck in overall study conduct. Numerous factors can adversely impact study startup, such as contract and budget negotiations, regulatory changes and compliance, IRB approvals, clinical staff turnover, and others, contributing to significant trial delays and cost overages.
TFS is a technology-driven CRO and recently partnered with goBalto. Their workflow-driven platform optimize the many study startup steps, providing real-time insights into study status, making it easier to quantify team performance and discover meaningful patterns in study data.
Thursday, May 24
10 am ET
7 am PT
VP Clinical Development
"Ed has over 25 years' experience in the life-sciences and healthcare industries, building and leading teams in clinical operations as well as portfolio and partnership management. He has extensive experience in global management across regions and countries. Prior to joining TFS Ed was the Sr. Director & Global Delivery Head, Customer Operations at Quintiles, and his career includes clinical management positions at PPD, Novartis, Sanofi-Sythelabo, AstraZeneca, and Alcon. Ed holds a Bachelor of Science (BS) degree in Biology from Villanova University."
Senior Director, Product Strategy
Elvin is a recognized industry expert in clinical trials, having over twenty years of experience working as a Clinical Business Analyst Consultant at major pharmaceutical companies including, Hoffmann-La Roche and Johnson & Johnson. Elvin works as a product strategist and system architect in goBalto’s effort to optimize Study Startup. Elvin is the co-chair on the TMF Reference Model Exchange Mechanism and holds a Master of Science in Industrial Engineering from Aalborg Universitet.